- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 233/00 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patent holdings for IPC class C07D 233/00
Total number of patents in this class: 152
10-year publication summary
|
7
|
8
|
3
|
4
|
4
|
2
|
2
|
1
|
3
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4883 |
8 |
| Arkema France | 3887 |
5 |
| Boehringer Ingelheim International GmbH | 4756 |
4 |
| Novartis AG | 11289 |
3 |
| Merck Sharp & Dohme Corp. | 2219 |
2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 96 |
2 |
| Allergan, Inc. | 2445 |
2 |
| Takeda Pharmaceutical Company Limited | 2945 |
2 |
| Antecip Bioventures II LLC | 316 |
2 |
| Auburn University | 499 |
2 |
| Kyushu University, National University Corporation | 1625 |
2 |
| PGI Drug Discovery LLC | 27 |
2 |
| Rutgers, The State University of New Jersey | 1843 |
2 |
| Sigma-Aldrich Co., LLC | 244 |
2 |
| Sumitomo Riko Company Limited | 1013 |
2 |
| Sunovion Pharmaceuticals Inc. | 297 |
2 |
| (chan-n) Changzhou Green Photosensitive Materials Co., Ltd. | 6 |
2 |
| Merck Sharp & Dohme LLC | 3744 |
2 |
| Glaxo Group Limited | 4283 |
1 |
| F. Hoffmann-La Roche AG | 7939 |
1 |
| Other owners | 102 |